ENTtoday
  • Home
  • COVID-19
  • Practice Focus
    • Allergy
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Departments
    • Issue Archive
    • TRIO Best Practices
      • Allergy
      • Facial Plastic/Reconstructive
      • Head and Neck
      • Laryngology
      • Otology/Neurotology
      • Pediatric
      • Rhinology
      • Sleep Medicine
    • Career Development
    • Case of the Month
    • Everyday Ethics
    • Health Policy
    • Legal Matters
    • Letter From the Editor
    • Medical Education
    • Online Exclusives
    • Practice Management
    • Resident Focus
    • Rx: Wellness
    • Special Reports
    • Tech Talk
    • Viewpoint
    • What’s Your O.R. Playlist?
  • Literature Reviews
    • Allergy
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Events
    • Featured Events
    • TRIO Meetings
  • Contact Us
    • About Us
    • Editorial Board
    • Triological Society
    • Advertising Staff
    • Subscribe
  • Advertise
    • Place an Ad
    • Classifieds
    • Rate Card
  • Search

Juul Suspends U.S. Advertising, CEO Steps Down

by Mary Beth Nierengarten • September 27, 2019

  • Tweet
  • Email
Print-Friendly Version

In late September, Juul Labs, which manufactures flavored e-cigarettes, announced it would suspend all broadcast, print, and digital product advertising in the United States, and that its CEO Ken Burns would step down. The statement comes as regulators assess multiple cases of what appears to be a vaping-related lung disease.

You Might Also Like

  • Longitudinal studies suggest e-cigarettes to be no more effective than already existing smoking cessation product
  • COSM 2012: TRIO Guest of Honor Cautions against Physician Advertising
  • Legal Steps That Need To Be Taken Before You Can Leave Your Medical Practice
  • EMR and Advertising: Strange Bedfellows?

The FDA recently found Juul’s advertising campaign, which touted its vaping products as safer alternatives to cigarettes, to be illegal because of the lack of supportive scientific evidence. On September 9, the FDA issued a warning letter to Juul stating that it needs to correct its marketing or risk being fined or having its vaping products seized.

In its September statement, Juul also said it would not push back on a Trump administration plan to pull fruit-flavored vaping products from the market until the controversial products win approval from FDA regulators, in an attempt to make the products less available to young consumers.

In the statement, Juul officials said the company will be “refraining from lobbying the administration on its draft guidance” that proposes banning fruit-flavored vaping products, unless approved by the FDA.

Apology for Teen Addiction

On July 15, Juul Labs CEO Kevin Burns issued an apology to parents of children who have become addicted to vaping products made by the company. Aired on a CNBC documentary, “Vaporized: America’s E-cigarette Addiction,” Burns’ apology was followed by the explanation that vaping products were never meant for teens. “First of all, I’d tell [parents] that I’m sorry that their child’s using the product,” said Burns. “It’s not intended for them. I hope there was nothing that we did that made it appealing to them.”

According to the company, Juul’s vaping products are intended for adults who are trying to quit smoking. Last year, however, approximately three million high school students in the U.S. used these products. Whether the dramatic rise in teen vaping is an unintended consequence of introducing this new type of product to the market or a consequence that, at least, could have been predicted, given an advertising campaign that uses social media platforms popular among teens, the FDA has called it an epidemic.

Filed Under: Online Exclusives Tagged With: e-cigarettes, vaping

You Might Also Like:

  • Longitudinal studies suggest e-cigarettes to be no more effective than already existing smoking cessation product
  • COSM 2012: TRIO Guest of Honor Cautions against Physician Advertising
  • Legal Steps That Need To Be Taken Before You Can Leave Your Medical Practice
  • EMR and Advertising: Strange Bedfellows?

The Triological SocietyENTtoday is a publication of The Triological Society.

The Laryngoscope
Ensure you have all the latest research at your fingertips; Subscribe to The Laryngoscope today!

Laryngoscope Investigative Otolaryngology
Open access journal in otolaryngology – head and neck surgery is currently accepting submissions.

Classifieds

View the classified ads »

TRIO Best Practices

View the TRIO Best Practices »

Top Articles for Residents

  • Do Training Programs Give Otolaryngology Residents the Necessary Tools to Do Productive Research?
  • Why More MDs, Medical Residents Are Choosing to Pursue Additional Academic Degrees
  • What Physicians Need to Know about Investing Before Hiring a Financial Advisor
  • Tips to Help You Regain Your Sense of Self
  • Should USMLE Step 1 Change from Numeric Score to Pass/Fail?
  • Popular this Week
  • Most Popular
  • Most Recent
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment
    • Vertigo in the Elderly: What Does It Mean?
    • Experts Delve into Treatment Options for Laryngopharyngeal Reflux
    • Weaning Patients Off of PPIs
    • Some Laryngopharyngeal Reflux Resists PPI Treatment
    • Vertigo in the Elderly: What Does It Mean?
    • New Developments in the Management of Eustachian Tube Dysfunction
    • Some Laryngopharyngeal Reflux Resists PPI Treatment
    • Eustachian Tuboplasty: A Potential New Option for Chronic Tube Dysfunction and Patulous Disease
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment
    • Did You Receive COVID-19 Relief? Here Are Reporting Considerations for 2021
    • Otolaryngology Experts Share Best Practices in Five Areas
    • How Climate Change May Be Affecting Sleep Patterns for Adults and Children
    • Laryngologists Discuss Tough Tracheostomy Choices During COVID-19 Era
    • Head and Neck Cancer: Experts Discuss How to Improve Surgery Quality and Value

Polls

Did you receive funding from the CARES Act or Paycheck Protection Program?

View Results

Loading ... Loading ...
  • Polls Archive
  • Home
  • Contact Us
  • Advertise
  • Privacy Policy
  • Terms of Use

Visit: The Triological Society • The Laryngoscope • Laryngoscope Investigative Otolaryngology

Wiley
© 2021 The Triological Society. All Rights Reserved.
ISSN 1559-4939

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.